The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure

Giuseppe Chiossi, Maged Costantine, Egle Bytautiene, Talar Kechichian, Gary Hankins, Elena Sbrana, George Saade, Monica Longo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective To estimate the effects of prostaglandin E1 (PGE1) and E2 (PGE2) on myometrial contractility and structure in vitro. Study Design Myometrial strips from 18 women were incubated with PGE1 (105 mol/L), PGE2 (105 mol/L), or solvent (CTR) for up to 360 minutes in organ chambers for isometric tension recording. The area under the contraction curve, total collagen content, and percentage of the area covered by connective tissue were calculated at various time periods. Results PGE1 significantly increased in vitro myometrial contractility up to 90 minutes when compared with PGE2 and CTR (p < 0.01) and up to 180 minutes as compared with PGE2 (p < 0.05). After 360 minutes, CTR and PGE1 samples had lower total collagen content and area covered by connective tissue than PGE2 (p < 0.01). Conclusion The effects of prostaglandins on the uterus cannot be solely explained by contractility. Treatment with PGE1 significantly increased myometrial contractions and decreased both total collagen content and the area covered by connective tissue. Such findings may explain the higher rates of vaginal delivery, tachysystole, and uterine rupture associated with PGE1 use.

Original languageEnglish (US)
Pages (from-to)615-621
Number of pages7
JournalAmerican Journal of Perinatology
Volume29
Issue number8
DOIs
StatePublished - 2012

Fingerprint

Alprostadil
Dinoprostone
Connective Tissue
Collagen
In Vitro Techniques
Uterine Rupture
Uterine Contraction
Uterus
Area Under Curve
Prostaglandins

Keywords

  • collagen
  • organ chamber
  • prostaglandin E1
  • prostaglandin E2
  • uterine contractility

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Chiossi, G., Costantine, M., Bytautiene, E., Kechichian, T., Hankins, G., Sbrana, E., ... Longo, M. (2012). The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure. American Journal of Perinatology, 29(8), 615-621. https://doi.org/10.1055/s-0032-1311986

The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure. / Chiossi, Giuseppe; Costantine, Maged; Bytautiene, Egle; Kechichian, Talar; Hankins, Gary; Sbrana, Elena; Saade, George; Longo, Monica.

In: American Journal of Perinatology, Vol. 29, No. 8, 2012, p. 615-621.

Research output: Contribution to journalArticle

Chiossi, G, Costantine, M, Bytautiene, E, Kechichian, T, Hankins, G, Sbrana, E, Saade, G & Longo, M 2012, 'The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure', American Journal of Perinatology, vol. 29, no. 8, pp. 615-621. https://doi.org/10.1055/s-0032-1311986
Chiossi, Giuseppe ; Costantine, Maged ; Bytautiene, Egle ; Kechichian, Talar ; Hankins, Gary ; Sbrana, Elena ; Saade, George ; Longo, Monica. / The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure. In: American Journal of Perinatology. 2012 ; Vol. 29, No. 8. pp. 615-621.
@article{db901886103941d6bb2686f7ee7d77ae,
title = "The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure",
abstract = "Objective To estimate the effects of prostaglandin E1 (PGE1) and E2 (PGE2) on myometrial contractility and structure in vitro. Study Design Myometrial strips from 18 women were incubated with PGE1 (105 mol/L), PGE2 (105 mol/L), or solvent (CTR) for up to 360 minutes in organ chambers for isometric tension recording. The area under the contraction curve, total collagen content, and percentage of the area covered by connective tissue were calculated at various time periods. Results PGE1 significantly increased in vitro myometrial contractility up to 90 minutes when compared with PGE2 and CTR (p < 0.01) and up to 180 minutes as compared with PGE2 (p < 0.05). After 360 minutes, CTR and PGE1 samples had lower total collagen content and area covered by connective tissue than PGE2 (p < 0.01). Conclusion The effects of prostaglandins on the uterus cannot be solely explained by contractility. Treatment with PGE1 significantly increased myometrial contractions and decreased both total collagen content and the area covered by connective tissue. Such findings may explain the higher rates of vaginal delivery, tachysystole, and uterine rupture associated with PGE1 use.",
keywords = "collagen, organ chamber, prostaglandin E1, prostaglandin E2, uterine contractility",
author = "Giuseppe Chiossi and Maged Costantine and Egle Bytautiene and Talar Kechichian and Gary Hankins and Elena Sbrana and George Saade and Monica Longo",
year = "2012",
doi = "10.1055/s-0032-1311986",
language = "English (US)",
volume = "29",
pages = "615--621",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "8",

}

TY - JOUR

T1 - The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure

AU - Chiossi, Giuseppe

AU - Costantine, Maged

AU - Bytautiene, Egle

AU - Kechichian, Talar

AU - Hankins, Gary

AU - Sbrana, Elena

AU - Saade, George

AU - Longo, Monica

PY - 2012

Y1 - 2012

N2 - Objective To estimate the effects of prostaglandin E1 (PGE1) and E2 (PGE2) on myometrial contractility and structure in vitro. Study Design Myometrial strips from 18 women were incubated with PGE1 (105 mol/L), PGE2 (105 mol/L), or solvent (CTR) for up to 360 minutes in organ chambers for isometric tension recording. The area under the contraction curve, total collagen content, and percentage of the area covered by connective tissue were calculated at various time periods. Results PGE1 significantly increased in vitro myometrial contractility up to 90 minutes when compared with PGE2 and CTR (p < 0.01) and up to 180 minutes as compared with PGE2 (p < 0.05). After 360 minutes, CTR and PGE1 samples had lower total collagen content and area covered by connective tissue than PGE2 (p < 0.01). Conclusion The effects of prostaglandins on the uterus cannot be solely explained by contractility. Treatment with PGE1 significantly increased myometrial contractions and decreased both total collagen content and the area covered by connective tissue. Such findings may explain the higher rates of vaginal delivery, tachysystole, and uterine rupture associated with PGE1 use.

AB - Objective To estimate the effects of prostaglandin E1 (PGE1) and E2 (PGE2) on myometrial contractility and structure in vitro. Study Design Myometrial strips from 18 women were incubated with PGE1 (105 mol/L), PGE2 (105 mol/L), or solvent (CTR) for up to 360 minutes in organ chambers for isometric tension recording. The area under the contraction curve, total collagen content, and percentage of the area covered by connective tissue were calculated at various time periods. Results PGE1 significantly increased in vitro myometrial contractility up to 90 minutes when compared with PGE2 and CTR (p < 0.01) and up to 180 minutes as compared with PGE2 (p < 0.05). After 360 minutes, CTR and PGE1 samples had lower total collagen content and area covered by connective tissue than PGE2 (p < 0.01). Conclusion The effects of prostaglandins on the uterus cannot be solely explained by contractility. Treatment with PGE1 significantly increased myometrial contractions and decreased both total collagen content and the area covered by connective tissue. Such findings may explain the higher rates of vaginal delivery, tachysystole, and uterine rupture associated with PGE1 use.

KW - collagen

KW - organ chamber

KW - prostaglandin E1

KW - prostaglandin E2

KW - uterine contractility

UR - http://www.scopus.com/inward/record.url?scp=84864994582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864994582&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1311986

DO - 10.1055/s-0032-1311986

M3 - Article

VL - 29

SP - 615

EP - 621

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 8

ER -